Avid Bioservices Inc (CDMO): Revs Guidance (FY’20 fye 4-30-20): $64...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	86
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: cjgaddy post# 331574

Monday, 12/09/2019 2:06:28 PM

Monday, December 09, 2019 2:06:28 PM

Revs Guidance
(FY’20 fye 4-30-20): $64-67M. 7-31-19 Backlog=$61M
*Cash: 7-31-19: $28.9M
*As of 8-31-19: 56,237,674 shares o/s.

Attaching this to CJs post in case one wants to read the entire post...

....and to compare to 4-30-19 numbers... with a comment from Hancock that they reached cash flow positive during that fye

Revs Guidance
(FY’20 fye 4-30-20): $64-67M. 4-30-19
Backlog=$46M as of 4-30-19
*Cash: 4-30-19: $32.4M
*As of 6-14-19: 56,137,724 shares o/s.
...
...
Hancock:
"Most importantly, during Q4, the Company achieved positive income, generating cash from development & mfg. operations for the 1st time since the beginning of the transition.
..."

Cash flow positive is cash flow positive and now it is very easy to tell when they manipulate the numbers ...

They already gave the yearly outlook..."before" signing a new contract with a top 10 Big Pharma and they failed to move the guidance up unless they are really ignorant but my guess is not...since some of the same BODs have reached good deals with ThermoFisher on other CDMOs they have in their pockets ...